Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia
Katsuhiko Hagi, Tadashi Nosaka, Dwight Dickinson, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 5, pp. 510-510
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 619
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1902-1918
Open Access | Times Cited: 323
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
Antonio Vita, Wolfgang Gäebel, Armida Mucci, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 88
Severe mental illness: cardiovascular risk assessment and management
Christoffer Polcwiartek, Kevin O’Gallagher, Daniel J. Friedman, et al.
European Heart Journal (2024) Vol. 45, Iss. 12, pp. 987-997
Open Access | Times Cited: 23
Leucine-Restricted Diet Ameliorates Obesity-Linked Cognitive Deficits: Involvement of the Microbiota–Gut–Brain Axis
Danna Wang, Luyao Wang, Liuyang Han, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 24, pp. 9404-9418
Closed Access | Times Cited: 23
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
Christoph U. Correll, Celso Arango, Birgitte Fagerlund, et al.
European Neuropsychopharmacology (2024) Vol. 82, pp. 57-71
Open Access | Times Cited: 9
Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 9
The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation
Zhenlei Peng, Qiyu Jia, Junxiong Mao, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Clinical practice guidelines for assessment and management of cognitive impairment in schizophrenia
Sandeep Grover, Debadatta Mohapatra, Sridhar Vaitheswaran, et al.
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 1, pp. 65-83
Open Access | Times Cited: 1
Multidimensional outcome of first-episode psychosis: a network analysis
Manuel J. Cuesta, Gustavo J. Gil‐Berrozpe, Ana M. Sánchez-Torres, et al.
Psychological Medicine (2025) Vol. 55
Closed Access | Times Cited: 1
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1284-1292
Open Access | Times Cited: 32
Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline
Robin M. Murray, Emre Bora, Gemma Modinos, et al.
Schizophrenia Research (2022) Vol. 243, pp. 181-186
Closed Access | Times Cited: 30
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 18
Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
Tiannan Shao, Jing Huang, Yuxin Zhao, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset Psychosis
Gonzalo Salazar de Pablo, Victoria Rodríguez, Filippo Besana, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2024) Vol. 63, Iss. 7, pp. 684-697
Open Access | Times Cited: 8
The protective role of ginsenoside Rg3 in heart diseases and mental disorders
Lili Shi, Jinlan Luo, Xiupan Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials
Vikash Jaiswal, Aanchal Sawhney, Chikodili Nebuwa, et al.
Progress in Cardiovascular Diseases (2024) Vol. 85, pp. 45-53
Closed Access | Times Cited: 7
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 6
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Yafen Wang, Weicheng Meng, Zhixin Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
Systematic review and meta-analysis of retinal microvascular caliber in bipolar disorder, major depressive disorder, and schizophrenia
Kody G. Kennedy, Megan Mio, Benjamin I. Goldstein, et al.
Journal of Affective Disorders (2023) Vol. 331, pp. 342-351
Closed Access | Times Cited: 11
Electroretinographic dysfunction, insulin resistance, and childhood trauma in early-course psychosis: A case-control exploratory study
Erik Velez-Perez, Nicolas Raymond, Chelsea Kiely, et al.
Biomarkers in Neuropsychiatry (2024) Vol. 10, pp. 100088-100088
Open Access | Times Cited: 4
Effects of obesity on aging brain and cognitive decline: a cohort study from the UK Biobank
Panlong Li, Xirui Zhu, Chun Huang, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 148-157
Closed Access
Impact of Probiotic Treatment on Clinical Symptom Reduction in Schizophrenia: A Systematic Review and Meta-Analysis
Verónica Romero‐Ferreiro, Lorena García‐Fernández, Carmen Romero, et al.
Journal of Psychiatric Research (2025) Vol. 182, pp. 413-420
Closed Access
Two Hypotheses on the High Incidence of Dementia in Psychotic Disorders
Katherine Jonas, Anissa Abi‐Dargham, Roman Kotov
JAMA Psychiatry (2021) Vol. 78, Iss. 12, pp. 1305-1305
Open Access | Times Cited: 24
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia
Nina Dalkner, Raeanne C. Moore, Colin A. Depp, et al.
Schizophrenia Research (2023) Vol. 252, pp. 1-9
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top